PerkinElmer Inc. DL-Notes 2021(21/28)
- BID
93.917
- ASK
94.064
- 500,000 Nom.500,000 Nom.
- 07/27, 19:45:06 PM
Type of financial instrument
Corporate Bond
Sub-Type
Health Care
Yield
5.00
Yield spread Bundesanleihe
2.2208
Tradable for private investors
No
Minimum amount tradeable unit
2,000.00
Maturity
15/09/2028
Interest Rate
1.90 %
Currency
US Dollar
Facts & figures
Price data
| TRADE PLATFORM | ||
| LAST PRICE / YIELD | 93.941 G / 5.00 | 0 Units |
| PRICE DETERMINATION TIME | 07/27/2026 / 07:02:07 PM | |
| DAILY VOLUME (NOMINAL) | 0 | |
| YIELD SPREAD | 2.2208 | |
| FIXINGPRICE | - | |
| DAILY HIGH / LOW | 93.96 | 93.9 |
| PREV. DAY'S PRICE | 93.921 | (07/24) |
| CHANGE DAY BEFORE | +0.02 | 0.02 % |
| 52 WEEK HIGH / LOW | 94.701 (02/27) | 91.63 (07/29) |
Master Data
| WKN | A3KV7N |
| ISIN | US714046AM14 |
| SYMBOL | - |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Corporate Bond |
| SUB-TYPE | Health Care |
| ISSUER | PerkinElmer Inc. |
| S&P RATING | Please log in to view this field |
| (TRADING) SEGMENT / TICKS | -/ - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| INTEREST RATE | 1.90 % |
| INTEREST RUN FROM | 10/09/2021 |
| NEXT INTEREST PAYMENT | 15/09/2026 |
| UNIT INTEREST FROM NOMINAL AMMOUNT | 0.707 % |
| TRADING CURRENCY / NOTATION | US Dollar/ Percent |
| NOMINAL CURRENCY | US Dollar |
| SETTLEMENT CURRENCY | Euro |
| QUOTATION | Continuous trading |
| ISSUING VOLUME | 500.00 Mil. |
| MINIMUM AMOUNT TRADEABLE UNIT | 2,000.00 |
| SMALLEST TRADEABLE UNIT | 1,000.00 |
| MATURITY | 15/09/2028 |
| MARKET MAKER | - |
| STEP UP/ DOWN WHEN RATING CHANGES | No |
| STEP UP FIXED AT ISSUE | No |
| STEP DOWN FIXED AT ISSUE | No |
| BOND CALLABLE BY THE ISSUER | Yes |
| BOND IS SUBORDINATED | No |
Description
Local currency bond: USD. Make Whole Call Option. Callable bond.
Tradability Information
Please log in to see the tradability information for this stock.Not registered yet? Create your free account here.
Company profile
Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. The firm operates through the following segments: Life Sciences and Diagnostics. The Life Sciences segment delivers innovative solutions to optimize workflows, boost productivity, and accelerate drug discovery and development. The Diagnostics segment provides instruments, reagents, assay platforms, and software to healthcare and research professionals, with a focus on reproductive health, immunodiagnostics, emerging market diagnostics, and applied genomics to enhance patient outcomes. Revvity was founded on April 19, 1937 and is headquartered in Waltham, MA.